LabMinds

About:

LabMinds is the leader in AI and robotics for solution preparation in pharmaceutical and life science labs.

Website: http://labminds.com

Twitter/X: LabMindsInc

Top Investors: Waters Corporation, Red Deer Capital, ACF Investors, Oxford Technology Management, VentureFounders

Description:

LabMinds is the leader in AI and robotics for solution preparation in pharmaceutical and life science labs. A cornerstone of R&D and QA/QC processes, solution preparation continues to be a highly manual process with many moving parts, exposing labs to considerable risk and inevitable waste. LabMinds’ platform addresses these challenges with powerful AI software combined with state-of-the-art robotics to safeguard against tainted inputs, enable near-perfect accuracy, and attain unmatched control. Further, labs in the LabMinds network contribute to, and benefit from, the collection of input and sensor data throughout the solution prep process; it’s never been easier to gain detailed insight into how chemicals interact with each other. By implementing more security and order, and leveraging the power of big data, LabMinds moves ever closer to achieving its mission to enable scientists and businesses to build and optimize labs, in order to bring meaningful therapies to market sooner.

Total Funding Amount:

$9.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Somerville, Massachusetts, United States

Founded Date:

2009-09-11

Contact Email:

contact(AT)labminds.com

Founders:

Camilla Oxley, Jochen W. Klingelhoefer, Ville Lehtonen

Number of Employees:

11-50

Last Funding Date:

2021-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai